Ribostamycin is an aminoglycoside antibiotic used to treat Gram-negative bacterial infections. It works by inhibiting bacterial protein synthesis, leading to cell death. Commonly used in veterinary medicine and microbiology research. Sometimes used as a selective agent in genetic engineering. It is grouped under the following drug class(es): Aminoglycosides. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Vistamycin, Ribostamycinum, Hetangmycin and Xylostatin. Its PubChem CID is 33042.
Ribostamycin
| CAS No | 25546-65-0 |
|---|---|
| Molecular Formula | C17H34N4O10 |
| Molecular Weight | 454.5 g/mol |
| Synonyms | (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ribostamycin is an aminoglycoside antibiotic used to treat Gram-negative bacterial infections. It works by inhibiting bacterial protein synthesis, leading to cell death.
The listed CAS number is 25546-65-0.
The listed molecular formula is C17H34N4O10.
The listed molecular weight is 454.5 g/mol.
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol.
The source lists Vistamycin, Ribostamycinum, Hetangmycin and Xylostatin.